HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ping Tang Selected Research

Breast Neoplasms (Breast Cancer)

8/2017Update on Immunohistochemical Analysis in Breast Lesions.
1/2017Genomic Pathology and Biomarkers in Breast Cancer.
9/2014A new rabbit monoclonal E-cadherin antibody [EP700Y] shows higher sensitivity than mouse monoclonal E-cadherin [HECD-1] antibody in breast ductal carcinomas and does not stain breast lobular carcinomas.
7/2014Folate receptor α associated with triple-negative breast cancer and poor prognosis.
7/2014The preparation of VEGFR1/CD3 bispecific antibody and its specific cytotoxicity against VEGFR1-positive breast cancer cells.
3/2013Second harmonic generation reveals matrix alterations during breast tumor progression.
4/2012Predictors of nipple-areolar complex involvement by breast carcinoma: histopathologic analysis of 787 consecutive therapeutic mastectomy specimens.
4/2012The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.
1/2012Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.
11/2010A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ping Tang Research Topics

Disease

38Neoplasms (Cancer)
11/2021 - 01/2006
19Prostatic Neoplasms (Prostate Cancer)
09/2021 - 03/2010
19Breast Neoplasms (Breast Cancer)
08/2017 - 01/2003
8Leukemia
04/2022 - 12/2008
8Carcinoma (Carcinomatosis)
05/2020 - 01/2003
7Ductal Carcinoma
02/2016 - 01/2007
6Noninfiltrating Intraductal Carcinoma (DCIS)
01/2009 - 01/2006
5Neoplasm Metastasis (Metastasis)
09/2021 - 12/2008
5Infections
12/2019 - 08/2016
4Thrombosis (Thrombus)
10/2020 - 03/2019
4Pathologic Constriction (Stenosis)
10/2020 - 03/2019
4Inflammation (Inflammations)
01/2020 - 03/2010
4Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2017 - 10/2010
3Venous Thrombosis (Deep-Vein Thrombosis)
07/2021 - 03/2019
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2019 - 11/2017
3Hepatocellular Carcinoma (Hepatoma)
01/2019 - 01/2012
3Lobular Carcinoma
09/2014 - 10/2010
2Neoplasms, Cystic, Mucinous, and Serous
01/2022 - 11/2017
2Ventricular Heart Septal Defects (Ventricular Septal Defect)
01/2022 - 01/2021
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2021 - 08/2016
2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
12/2021 - 12/2008
2Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 01/2018
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2020 - 01/2020
2Iron Deficiencies
04/2019 - 12/2018
2Myopia
08/2018 - 05/2003
2Triple Negative Breast Neoplasms
08/2016 - 07/2014
2Carcinogenesis
06/2009 - 02/2007
2Cataract (Cataracts)
01/2006 - 05/2003
1Stomach Neoplasms (Stomach Cancer)
08/2022
1Papillary Thyroid Cancer
04/2022
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
02/2022
1Multiple Sclerosis
02/2022
1Demyelinating Diseases (Demyelinating Disease)
02/2022
1Familial Primary Pulmonary Hypertension
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Vitamin D Deficiency
01/2022
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2021
1Bronchiolitis Obliterans Syndrome
10/2021
1Vascular System Injuries
07/2021

Drug/Important Bio-Agent (IBA)

15Prostate-Specific Antigen (Semenogelase)IBA
03/2019 - 03/2010
10Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2009
10Biomarkers (Surrogate Marker)IBA
01/2022 - 03/2011
10Phenobarbital (Luminal)FDA Link
08/2016 - 01/2006
9Estrogen ReceptorsIBA
08/2017 - 03/2008
9Progesterone Receptors (Progesterone Receptor)IBA
07/2014 - 01/2006
6ErbB Receptors (EGF Receptor)IBA
01/2019 - 01/2006
6Androgen Receptors (Androgen Receptor)IBA
08/2017 - 03/2008
6Keratins (Keratin)IBA
10/2010 - 01/2006
5MicroRNAs (MicroRNA)IBA
09/2021 - 11/2017
4Pharmaceutical PreparationsIBA
01/2019 - 10/2012
4AntibodiesIBA
01/2009 - 01/2006
3Therapeutic UsesIBA
03/2021 - 06/2012
3Sirtuin 1IBA
10/2020 - 03/2019
3Neutralizing AntibodiesIBA
12/2019 - 01/2019
3CytokinesIBA
03/2019 - 08/2015
3Biological ProductsIBA
01/2019 - 01/2006
3Proteasome Endopeptidase Complex (Proteasome)IBA
04/2018 - 01/2012
3AndrogensIBA
10/2014 - 01/2012
2CateninsIBA
08/2022 - 09/2014
2AntigensIBA
04/2022 - 10/2017
2EnzymesIBA
01/2022 - 06/2014
2ImmunosorbentsIBA
01/2022 - 06/2014
2MonocrotalineIBA
01/2022 - 02/2004
2Polidocanol (Laureth)FDA Link
01/2022 - 11/2017
2Glucose (Dextrose)FDA LinkGeneric
10/2020 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
03/2020 - 08/2015
2AcidsIBA
04/2019 - 12/2018
2ChymotrypsinFDA Link
04/2018 - 06/2015
2Indicators and Reagents (Reagents)IBA
01/2018 - 04/2012
2CD40 Ligand (CD40L)IBA
01/2017 - 10/2012
2Proteasome InhibitorsIBA
10/2014 - 01/2012
2Cadherins (E-Cadherin)IBA
09/2014 - 12/2010
2Fibrillar CollagensIBA
03/2013 - 02/2008
2CollagenIBA
03/2013 - 02/2008
2UbiquitinIBA
10/2012 - 04/2012
2Estrogen Receptor alphaIBA
12/2008 - 01/2006
1Sijunzi decoctionIBA
08/2022
1lenvatinibIBA
04/2022
1Natalizumab (Tysabri)FDA Link
02/2022
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
02/2022
1PropionatesIBA
01/2022
1LactoferrinIBA
01/2022
1Notch ReceptorsIBA
12/2021
1Circular RNAIBA
12/2021
1Blood Proteins (Serum Proteins)IBA
10/2021
1Monomeric GTP-Binding ProteinsIBA
09/2021
1Glutathione PeroxidaseIBA
07/2021
1ferric chlorideIBA
07/2021
1AntioxidantsIBA
07/2021
1Glutathione Reductase (Glutathione-Disulfide Reductase)IBA
07/2021
1Superoxide DismutaseIBA
07/2021
1ArsenicIBA
06/2021

Therapy/Procedure

17Therapeutics
11/2021 - 02/2007
6Drug Therapy (Chemotherapy)
01/2019 - 12/2014
3Prostatectomy (Retropubic Prostatectomy)
11/2013 - 12/2010
2Hematopoietic Stem Cell Transplantation
11/2021 - 10/2021
2Aftercare (After-Treatment)
01/2021 - 12/2010
2Stents
10/2020 - 01/2020
2Phacoemulsification
01/2006 - 05/2003
1Perforator Flap
11/2021